UB Paderborn / Katalog / Suche / in CDI

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2020-05, Vol.23 (3), p.373-381

2020

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Increasing Hospital Volume on 90-Day Postoperative Outcomes Following Pancreaticoduodenectomy

Journal of gastrointestinal surgery, 2017-03, Vol.21 (3), p.506-515

2017

Link zum Volltext

Verfügbarkeit prüfen

Healthcare and Cancer Treatment Costs of Breast Screening Outcomes among Higher than Average Risk Women

Current oncology (Toronto), 2023-09, Vol.30 (9), p.8550-8562

2023

Link zum Volltext

Verfügbarkeit prüfen

Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada

BMC cancer, 2020-04, Vol.20 (1), p.304-304, Article 304

2020

Link zum Volltext

Verfügbarkeit prüfen

Real‐world outcomes of FOLFIRINOX vs gemcitabine and nab‐paclitaxel in advanced pancreatic cancer: A population‐based propensity score‐weighted analysis

Cancer medicine (Malden, MA), 2020-01, Vol.9 (1), p.160-169

2020

Link zum Volltext

Verfügbarkeit prüfen

Advantages of the net benefit regression framework for trial-based economic evaluations of cancer treatments: an example from the Canadian Cancer Trials Group CO.17 trial

BMC cancer, 2019-06, Vol.19 (1), p.552-552, Article 552

2019

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients

JAMA : the journal of the American Medical Association, 2014-11, Vol.312 (20), p.2135

2014

Link zum Volltext

Verfügbarkeit prüfen

Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol

BMC cancer, 2019-09, Vol.19 (1), p.884-884, Article 884

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of Disability Status on Ischemic Stroke Costs in Canada in the First Year

Canadian journal of neurological sciences, 2012-11, Vol.39 (6), p.793-800

2012

Link zum Volltext

Verfügbarkeit prüfen

Using Real-World Data to Determine Health System Costs of Ontario Women Screened for Breast Cancer

Current oncology (Toronto), 2022-10, Vol.29 (11), p.8330-8339

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase-specific healthcare costs of cervical cancer: estimates from a population-based study

American journal of obstetrics and gynecology, 2016-05, Vol.214 (5), p.615.e1-615.e11

2016

Link zum Volltext

Verfügbarkeit prüfen

Changes in healthcare costs and survival in the era of immunotherapy and targeted systemic therapy for melanoma

International journal of population data science, 2022-08, Vol.7 (3)

2022

Link zum Volltext

Verfügbarkeit prüfen

Pain and Interventions in Stage IV Non-Small Cell Lung Cancer: A Province-Wide Analysis

Current oncology (Toronto), 2023-03, Vol.30 (3), p.3461-3472

2023

Link zum Volltext

Verfügbarkeit prüfen

Cost‐effectiveness of second‐line ipilimumab for metastatic melanoma: A real‐world population‐based cohort study of resource utilization

Cancer medicine (Malden, MA), 2023-05, Vol.12 (10), p.11451-11461

2023

Link zum Volltext

Verfügbarkeit prüfen

A Canadian Prospective Study of Linkage of Randomized Clinical Trial to Cancer and Mortality Registry Data

Current oncology (Toronto), 2021-03, Vol.28 (2), p.1153-1160

2021

Link zum Volltext

Verfügbarkeit prüfen

Variable participation of knowledge users in cancer health services research: results of a multiple case study

BMC medical research methodology, 2018-11, Vol.18 (1), p.150-150, Article 150

2018

Link zum Volltext

Verfügbarkeit prüfen

Quantitative analysis of multiple sclerosis patients’ preferences for drug treatment: a best–worst scaling study

Therapeutic advances in neurological disorders, 2016-07, Vol.9 (4), p.287-296

2016

Link zum Volltext

Verfügbarkeit prüfen

The Past, Present, and Future of Economic Evaluations of Precision Medicine at the Committee for Economic Analyses of the Canadian Cancer Trials Group

Current oncology (Toronto), 2021-09, Vol.28 (5), p.3649-3658

2021

Link zum Volltext

Verfügbarkeit prüfen

Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial

Current oncology (Toronto), 2021-03, Vol.28 (2), p.1256-1261

2021

Link zum Volltext

Verfügbarkeit prüfen

A large cluster randomized trial of outcome-based pathways to improve home-based wound care

Trials, 2017-08, Vol.18 (1), p.393-393, Article 393

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 291

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(283)
Mit Volltextzugriff
(271)

Publikationsform

Artikel
(291)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Impact of aggressive management and palliative care on cancer costs in the final month of life

The impact of routine Edmonton Symptom Assessment System (ESAS) use on overall survival in cancer patients: Results of a population‐based retrospective matched cohort analysis

Does early palliative identification improve the use of palliative care services?

Quality of anticoagulant control and patient experience associated with long-term warfarin in Canadian patients with non-valvular atrial fibrillation: A multicentre, prospective study

Economic impacts of care by high-volume providers for non-curative esophagogastric cancer: a population-based analysis

The Impact of Increasing Hospital Volume on 90-Day Postoperative Outcomes Following Pancreaticoduodenectomy

Healthcare and Cancer Treatment Costs of Breast Screening Outcomes among Higher than Average Risk Women

Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I)

Real-world comparative effectiveness of second-line ipilimumab for metastatic melanoma: a population-based cohort study in Ontario, Canada

Real‐world outcomes of FOLFIRINOX vs gemcitabine and nab‐paclitaxel in advanced pancreatic cancer: A population‐based propensity score‐weighted analysis

Advantages of the net benefit regression framework for trial-based economic evaluations of cancer treatments: an example from the Canadian Cancer Trials Group CO.17 trial

Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients

Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol

Impact of Disability Status on Ischemic Stroke Costs in Canada in the First Year

Using Real-World Data to Determine Health System Costs of Ontario Women Screened for Breast Cancer

Phase-specific healthcare costs of cervical cancer: estimates from a population-based study

Changes in healthcare costs and survival in the era of immunotherapy and targeted systemic therapy for melanoma

Pain and Interventions in Stage IV Non-Small Cell Lung Cancer: A Province-Wide Analysis

Cost‐effectiveness of second‐line ipilimumab for metastatic melanoma: A real‐world population‐based cohort study of resource utilization

A Canadian Prospective Study of Linkage of Randomized Clinical Trial to Cancer and Mortality Registry Data

Variable participation of knowledge users in cancer health services research: results of a multiple case study

Quantitative analysis of multiple sclerosis patients’ preferences for drug treatment: a best–worst scaling study

The Past, Present, and Future of Economic Evaluations of Precision Medicine at the Committee for Economic Analyses of the Canadian Cancer Trials Group

Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial

A large cluster randomized trial of outcome-based pathways to improve home-based wound care

Suchergebnisse filtern